The Blood-Brain Barrier and Nasal Drug Delivery to the Central Nervous System

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Rhinology & Allergy

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2500/ajra.2015.29.4149PMID 25785753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty of 1000 evaluation for Getting into the brain: approaches to enhance brain drug delivery.

  2016cited by this paper
• Intrathecal delivery of protein therapeutics to the brain: a critical reassessment.

  2014cited by this paper
• Drug delivery across the blood-brain barrier.

  2013cited by this paper
• Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain

  2013cited by this paper
• Mucocele Rate after Endoscopic Skull Base Reconstruction Using Vascularized Pedicled Flaps

  2011cited by this paper
• Temporospatial quantification of fluorescein‐labeled sinonasal irrigation delivery

  2011cited by this paper
• Levodopa delivery systems: advancements in delivery of the gold standard

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone.

  2009cited by this paper
• CNS drug delivery systems: novel approaches.

  2009cited by this paper
• Getting into the Brain

  2009cited by this paper
• Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone

  2009cited by this paper
• Intrathecal drug delivery.

  2008cited by this paper
• Recent patents review on intranasal administration for CNS drug delivery.

  2008cited by this paper
• Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies

  2008cited by this paper
• Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

  2008cited by this paper
• Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugs

  2008cited by this paper
• Blood-brain barrier delivery.

  2007cited by this paper
• Direct Nose-to-Brain Transfer of Morphine After Nasal Administration to Rats

  2006cited by this paper
• Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.

  2006cited by this paper
• Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?

  2006cited by this paper
• Closure of cerebrospinal fluid leaks prevents ascending bacterial meningitis.

  2005cited by this paper
• Microdialysis evaluation of the brain distribution of stavudine following intranasal and intravenous administration to rats.

  2005cited by this paper
• Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents.

  2005cited by this paper
• Intranasal drug delivery for brain targeting.

  2005cited by this paper
• Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction.

  2004cited by this paper
• Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.

  2004cited by this paper
• Drug delivery across the blood-brain barrier.

  2004cited by this paper
• A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug.

  2004cited by this paper
• Practice guidelines for the management of bacterial meningitis.

  2004cited by this paper
• Uptake of Melatonin into the Cerebrospinal Fluid After Nasal and Intravenous Delivery: Studies in Rats and Comparison with a Human Study

  2004cited by this paper
• The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.

  2004cited by this paper
• Direct access of drugs to the human brain after intranasal drug administration?

  2003cited by this paper
• Impact of Drug Transporter Studies on Drug Discovery and Development

  2003cited by this paper
• Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

  2003cited by this paper
• Hydroxocobalamin Uptake into the Cerebrospinal Fluid after Nasal and Intravenous Delivery in Rats and Humans

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• William Pardridge discusses the lack of BBB research. Interview by Rebecca N. Lawrence.

  2002cited by this paper
• Sniffing neuropeptides: a transnasal approach to the human brain

  2002cited by this paper
• William Pardridge discusses the lack of BBB research

  2002cited by this paper
• Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier

  2002cited by this paper
• OLFACTORY TRANSPORT: A DIRECT ROUTE OF DELIVERY OF INHALED MANGANESE PHOSPHATE TO THE RAT BRAIN

  2002cited by this paper
• Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus

  2001cited by this paper
• Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

  2001cited by this paper
• Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.

  2001cited by this paper
• Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications.

  2001cited by this paper
• Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

  2001cited by this paper
• P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

  2000cited by this paper
• Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice

  2000cited by this paper
• Cell delivery to the central nervous system.

  2000cited by this paper
• Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

  1999cited by this paper
• Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems.

  1999cited by this paper
• Transfer of some carboxylic acids in the olfactory system following intranasal administration.

  1999cited by this paper
• Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat

  1998cited by this paper
• Leptomeningeal metastases: Rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?

  1998cited by this paper
• Intranasal angiotensin II directly influences central nervous regulation of blood pressure.

  1998cited by this paper
• Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study

  1998cited by this paper
• The entry of antiviral and antiretroviral drugs into the central nervous system.

  1997cited by this paper
• The Blood‐brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System

  1996cited by this paper
• Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.

  1996cited by this paper
• Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate

  1995cited by this paper
• Gene delivery into the central nervous system by nasal instillation in rats.

  1995cited by this paper
• Distribution of nerve growth factor following direct delivery to brain interstitium.

  1995cited by this paper
• Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier

  1995cited by this paper
• Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.

  1993cited by this paper
• Morphology of olfactory epithelium in humans and other vertebrates

  1992cited by this paper
• Di‐iodo‐l‐tyrosine‐labelled Dextrans as Molecular Size Markers of Nasal Absorption in the Rat

  1992cited by this paper
• Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study.

  1990cited by this paper
• Blood-brain barrier disruption using mannitol: time course and electron microscopy studies.

  1989cited by this paper
• Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study.

  1988cited by this paper
• One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

  1988cited by this paper
• Human blood-brain barrier transferrin receptor.

  1987cited by this paper

• The material–mucosa interface: A review of nanoformulations and biomaterials for overcoming transmucosal delivery barriers

  2026cites this paper
• HS15-based nanotherapeutics for direct nose-to-brain delivery against central nervous system fungal.

  2026cites this paper
• Practical and translational therapeutic elements for GBM therapy.

  2026cites this paper
• Virtual screening of drugs against multiple targets of Alzheimer's disease

  2025cites this paper
• Navigating the Neural Highway: Addressing Clinical Applications, Cost-Effectiveness, and Compliance of Microneedle Drug Delivery in Neurological Disorders

  2025cites this paper
• Improving the Treatment of Brain Gliomas Through Small-Particle-Size Paclitaxel-Loaded Micelles with a High Safety Profile

  2025cites this paper
• Nasal Delivery of Engineered Exosomes via a Thermo‐Sensitive Hydrogel Depot Reprograms Glial Cells for Spinal Cord Repair

  2025cites this paper
• Nasal-to-brain delivery of CCR5 antagonist for reshaping the dysregulated microglia-neuron axis and enhancing post-traumatic cognitive function.

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Engineering Elastin-Like Polypeptides for Polyphenol Capture and Permeation through an In Vitro Nasal Mucosa Barrier

  2025cites this paper
• Long-Chain Cyclic Arylguanidines as Multifunctional Serotonin Receptor Ligands with Antiproliferative Activity

  2025cites this paper
• Blood-brain barrier repair: potential and challenges of stem cells and exosomes in stroke treatment

  2025cites this paper
• Nasal Delivery of Phytochemicals Using Nanocarriers: Therapeutic Opportunities and Translational Challenges

  2025cites this paper
• Quality by Design of Ultra Deformable Nanovesicles Loaded with Flunarizine for Brain Targeting Utilizing Risk Assessment and Multivariate Analytical Methods

  2025cites this paper
• Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS

  2024cites this paper
• A Combinatorial Approach with Microneedle Pretreatment and Thermosensitive Gel Loaded with Rivastigmine Lipid Nanoparticle Formulation Enables Brain Delivery via the Trigeminal Nerve.

  2024cites this paper
• Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates.

  2024cites this paper
• Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drug

  2024cites this paper
• Characterizing regional drug delivery within the nasal airways

  2024cites this paper
• Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine

  2024cites this paper
• Transferosome-Based Intranasal Drug Delivery Systems for the Management of Schizophrenia: a Futuristic Approach

  2023cites this paper
• Development of hyaluronic acid-based microneedles for improved brain delivery of rivastigmine nanoparticles via mystacial pad region

  2023cites this paper
• Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis

  2023cites this paper
• Challenges with the discovery of RNA-based therapeutics for flaviviruses

  2023influential citation
• Multidrug-loaded liposomes prevent ischemic stroke through intranasal administration.

  2023cites this paper
• Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence

  2023cites this paper
• DESIGN AND DEVELOPMENT OF PHYTOSOMAL SOFT NANOPARTICLES FOR LIVER TARGETING

  2023cites this paper
• Novel therapeutic delivery for neurodegenerative diseases: Strategies to overcome CNS barriers

  2023cites this paper
• Nanogels, nanodiscs, yeast cells, and metallo-complexes-based curcumin delivery for therapeutic applications

  2023cites this paper
• Unraveling The Role of Chitosan for Nasal Drug Delivery Systems: A Review

  2023cites this paper
• The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment

  2022cites this paper
• FORMULATION STRATEGIES FOR NOSE-TO-BRAIN DRUG DELIVERY IN ALZHEIMER'S DISEASE

  2022cites this paper
• Therapeutic potential of plant iridoids in depression: a review

  2022influential citation
• A Comprehensive Review on Nanomedicine: Promising approach for treatment of brain tumor through intranasal administration.

  2022cites this paper
• Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System

  2022influential citation
• Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies

  2021cites this paper
• Neuroprotective Herbs for the Management of Alzheimer’s Disease

  2021cites this paper
• Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting

  2021cites this paper
• Drug delivery to the central nervous system

  2021cites this paper
• Intranasal route: The green corridor for Alzheimer's disease therapeutics

  2021cites this paper
• Self-assembling modified neuropeptide S enhances nose-to-brain penetration and exerts a prolonged anxiolytic-like effect.

  2021cites this paper
• Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery

  2020cites this paper
• Nanostructure self-assembly for direct nose-to-brain drug delivery

  2020cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Current Status and Challenges in Rotigotine Delivery.

  2020cites this paper
• Nose to brain drug delivery - a promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion.

  2020cites this paper
• Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review

  2020cites this paper
• Progress and perspectives on nanoplatforms for drug delivery to the brain

  2020cites this paper
• Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters

  2020cites this paper
• Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer's Disease: A Recent Update.

  2020cites this paper
• Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers

  2020influential citation
• Recent In Vitro and In Silico Advances in the Understanding of Intranasal Drug Delivery.

  2020cites this paper
• Estimation of absorbed radiation doses to skin and S-values for organs at risk due to nasal administration of PET agents using Monte Carlo simulations.

  2020cites this paper
• The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics

  2020cites this paper
• Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology

  2020cites this paper
• Drug delivery to the brain

  2019cites this paper
• α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition.

  2019cites this paper
• The involvement of perivascular spaces or tissues in the facial intradermal brain-targeted delivery

  2019cites this paper
• Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin

  2019cites this paper
• Mitral cells and the glucagon‐like peptide 1 receptor: The sweet smell of success?

  2019cites this paper
• Design and Fabrication of Brain-Targeted Drug Delivery

  2019cites this paper
• Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution

  2019cites this paper
• The Role of Aptamers in the Treatment of Glioblastoma Multiform

  2019cites this paper
• Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi‐center randomized parallel group clinical study

  2019cites this paper
• Lymphatic and blood systems: identical or fraternal twins?

  2019cites this paper
• ВЛИЯНИЕ ИМПЛАНТАЦИИ КАТЕТЕРА ДЛЯ ВНУТРИЧЕРЕПНЫХ ИНЪЕКЦИЙ НА МЕТАБОЛИЧЕСКИЙ ПРОФИЛЬ МИКРОГЛИИ КРЫС Е. Гурмач, М. Рудык, В. Святецкая, Л. Скивка

  2019cites this paper
• Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats

  2019cites this paper
• Intranasal Medication Delivery in Children for Brain Disorders

  2019cites this paper
• An application of nasal drug delivery for management of head and neck diseases from the perspective of Persian Medicine

  2019cites this paper
• The Role of Aptamers in the Treatment of Glioblastoma Multiform

  2019cites this paper
• Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia

  2018cites this paper
• Real-Time Data Acquisition System for Monitoring Focused Ultrasound Blood-Brain Barrier Opening

  2018cites this paper
• EFFECT OF INTRACRANIAL CATHETER PLACEMENT ON MICROGLIA METABOLIC PROFILE OF RATS

  2018cites this paper
• Effect of intranasal insulin on peripheral glucose profile in dexamethasone-induced insulin resistance in Wistar rats

  2018cites this paper
• Nanogels as potential drug nanocarriers for CNS drug delivery.

  2018cites this paper
• Prospective transfrontal sheep model of skull‐base reconstruction using vascularized mucosa

  2018cites this paper
• Turning Up Your Nose for a Flaviviral Encephalitis Cure

  2018cites this paper
• Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.

  2018cites this paper
• INTRANASAL DRUG DELIVERY-NEW CONCEPT OF THERAPEUTIC IMPLICATIONS FOR EFFECTIVE TREATMENT OF CNS DISORDERS

  2017cites this paper
• Estudio con criterios filogenéticos del potencial neuroprotector de líquenes parmeliáceos: mecanismos de acción de sus metabolitos secundarios

  2017cites this paper
• A strategy for bypassing the blood‐brain barrier: Facial intradermal brain‐targeted delivery via the trigeminal nerve

  2017influential citation
• Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases.

  2017cites this paper
• Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model

  2017cites this paper
• Role of butter oil in brain targeted delivery of Quetiapine fumarate microemulsion via intranasal route

  2017cites this paper
• Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting

  2017cites this paper
• Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications

  2017cites this paper
• Intranasal administration of brain‐targeted HP‐β‐CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia

  2017cites this paper
• Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone.

  2017cites this paper
• Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery

  2017cites this paper
• Diagnosis and Drug Delivery to the Brain

  2017cites this paper
• Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma

  2016cites this paper
• Chapter 1 The Potential Use of Plant-Derived Compounds in Glioblastoma Management

  2016cites this paper
• Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception

  2016cites this paper
• The effect of prolonged intranasal administration of serotonin on the activity of hypothalamic signaling systems in male rats with neonatal diabetes

  2016cites this paper
• The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders

  2016cites this paper
• Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil

  2016cites this paper
• Strategies to Improve Opioid Analgesia: Nociceptin Receptor Agonists and Intranasal Delivery in Monkeys.

  2016cites this paper
• Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

  2015cites this paper
• Editorial: New perspectives in the pathogenesis and management of rhinologic and allergic airway disease

  2015cites this paper
• Разделение речи целевого и сторонних дикторов с использованием двухмикрофонной системы

  2014cites this paper